Literature DB >> 3591895

Assessment of conjunctival hyperemia in contact lens wearers. Part II.

C W McMonnies, A Chapman-Davies.   

Abstract

A photographic reference scale has been used to grade conjunctival hyperemia in contact lens wearers. A sample of hard lens wearers, included as a control, has been found to have significantly less conjunctival hyperemia (p less than 0.01) than either of two soft lens wearing groups (one using preserved storage solutions and the other using unpreserved storage solutions). Because both soft lens samples were found to have more hyperemia, it is concluded that factors other than storage solution preservative contribute to increase conjunctival hyperemia in soft lens wearers. However, the preserved storage soft lens wearers had significantly more hyperemia than the unpreserved storage solution group (p less than 0.01). The conclusion is that, apart from acute and subacute responses, there may be a relatively benign chronic response to soft lens storage solution that is associated with minimal symptoms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591895     DOI: 10.1097/00006324-198704000-00004

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  3 in total

1.  Evaluation of regional bulbar redness using an image-based objective method.

Authors:  Wen-Juan Zhao; Fang Duan; Zhong-Ting Li; Hua-Jun Yang; Qiang Huang; Kai-Li Wu
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 2.  Non-invasive objective and contemporary methods for measuring ocular surface inflammation in soft contact lens wearers - A review.

Authors:  Cecilia Chao; Kathryn Richdale; Isabelle Jalbert; Kim Doung; Moneisha Gokhale
Journal:  Cont Lens Anterior Eye       Date:  2017-06-09       Impact factor: 3.077

3.  Altered Bulbar Conjunctival Microcirculation in Response to Contact Lens Wear.

Authors:  Wan Chen; Zhe Xu; Hong Jiang; Jin Zhou; Liang Wang; Jianhua Wang
Journal:  Eye Contact Lens       Date:  2017-03       Impact factor: 2.018

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.